Homes for Sale in East Bay (San Francisco Bay Area)
Real Estate: Danville homes, Alameda County homes, Contra Costa County homes, Concord homes, Walnut Creek homes, Livermore, East Bay homes, Berkeley, San Ramon Danville Alamo homes, Pleasanton homes, Hayward homes, Orinda Moraga Lafayette homes, Walnut Creek Concord Pleasant Hill homes, Dublin homes, Orinda homes, Moraga homes, Lafayette homes, Antioch, Castro Valley homes, San Ramon homes, San Leandro, Pleasant Hill homes, San Lorenzo, Clayton, Alamo homes

World News   USA   Bay Area   South SF   Business   Earnings
Homes for Sale in East Bay (San Francisco Bay Area)
South SF, Earnings Timeline Saturday, October 11     Author
To sell or purchase a home in South SF click here
Search Bay Area News Atlas:

3Q Profit Up 21 % On Cancer Drug Sales
World News World Earnings (98) USA (204) Bay Area Bay Area Earnings (241) South SF (93) Business (37) Earnings
2007 (2) 2006 (3) 2005 (4) 2004 (3) 2003 (2) 2002 (4) 2001 (2)
   Genentech (17)
Earnings on Wikipedia Earnings on Web Earnings Books
Real Estate

4Q Profit Rises 6 Percent
Jan.14
  Genentech: The biotech giant barely scraped past expectations as stock dropped in after-hours trading as sales of a key product also fell below expectations

year 2007 Top ^

Oct.16
  Genentech: The profit rose nearly 21% from a year ago, beating expectations by a penny thanks to stronger-than-expected sales of the Avastin
Jan.10 4Q Earnings Soar 75%
  Genentech: A strong demand for cancer-fighting drugs fueled a profit increase as company executives shook off doubts

year 2006 Top ^

Apr.12 Profit climbs by 48% in first quarter
  Genentech: Genentech Inc. raised its full-year earnings growth estimate to as much as 55% over 2005
Jan.12 Shares tumble  Genentech: Shares dropped more than 4% as investors reacted to an earnings report that met analysts' expectations Jan.11 Up 64% in quarter after good year
  Genentech: Earnings per share grew 63 percent to 31 cents as cancer drugs continued to build sales

year 2005 Top ^

May.24 Genentech up on drug data  Drug for a eye disease showed that it may stabilize or reverse the condition in a clinical trial Apr.12 Biotech giant's profit up 61%  Genentech: The colon cancer drug Avastin and other cancer drugs boost sales Jan.10 Profit surges, misses expectations by 1c  Genentech: Biotechnology titan reported a 63% surge in its fourth-quarter profits on strong sales of a string of new drugs

year 2004 Top ^

Apr.7 Profits surge on brisk cancer drug sales  Genentech: Biotechnology company yearlong hot streak continued when it reported robust profits for the first quarter Jan.14 Profits surge on strong drug sales  Genentech: The results, lifted by popular cancer-fighting drugs, beat analysts' expectations

year 2003 Top ^

Oct.8 Biotech titan posts higher profits  Genentech: Genentech is boosted by continued strong sales of its 2 blockbuster cancer-fighting drugs and a one-time legal settlement Jan.15 Reports continued strong earnings  Genentech: Profit in the fourth quarter more than doubled, but a $500 million legal setback detracted from an otherwise rosy year

year 2002 Top ^

Nov.7 CEO cashes in while shareholders lose  Dr. Louis Bucalo of Titan Pharmaceuticals legally cashed in 200,000 shares for about $9.5 million Aug.15 Ex-employee charged with insider trading  Genentech: Lei Wang, 32, a former Genentech programmer has agreed to pay $76,000 to settle charges Jan.16 Earnings rise  Genentech: Biotechnology company nearly tripled its earnings on the sales strength of its two cancer drugs

year 2001 Top ^

Oct.10 Profits rise  Genentech: 3rd quarter profits rose sixfold. The results exceeded expectations. Net income is $42.7 million Jul.11 Genentech meets expectations  Cancer drug Rituxan helped Genentech match estimates in the second quarter



Neighbor Real Estate:

Add a favorite (file a bookmark) to South SF, Earnings Timeline


Please send feedback to: support@mapreport.com

Advertise on South SF, Earnings Page